Objective-Vascular calcification is an important risk factor for cardiovascular diseases. Here, we investigated a role of dedifferentiated vascular smooth muscle cells (VSMCs) in the atherosclerotic intimal calcification. Methods and Results-We prepared human cultured VSMCs in either redifferentiatiated or dedifferentiated state and analyzed the gene expressions of bone-calcification regulatory factors. Expression of bone morphogenetic protein-2 (BMP-2), a potent initiator for osteoblast differentiation, was significantly enhanced in dedifferentiated VSMCs. Furthermore, endogenous BMP-2 antagonists, such as noggin, chordin, and matrix gamma-carboxyglutamic acid protein, were all downregulated in the dedifferentiated VSMCs. Conditioned medium from dedifferentiated VSMCs, but not from redifferentiated VSMCs, stimulated the osteoblastic differentiation of the mesenchymal progenitor C2C12 cells, which was abolished by BMP-2 knockdown. In atherosclerotic intima from apolipoprotein (apo)E-deficient mice, ␣SM-actin-positive cells, presumably dedifferentiated VSMCs, expressed BMP-2. We generated BMP-2-transgenic mice using ␣SM-actin promoter and crossed them with apoE-deficient mice (BMP-2-transgenic/apoE-knockout).
V ascular calcification has been an important risk factor for cardiovascular diseases as well as all-causal mortality. 1, 2 There are several types of vascular calcification, such as calcification in intima associated with atherosclerosis and calcification in tunica media (medial calcification), which is often observed in elderly people and patients with diabetes mellitus and/or chronic kidney disease. 3 Recently, we have reported an important role of senescent vascular smooth muscle cells (VSMCs) in the formation of medial calcification associated with aging. 4 However, the molecular mechanism(s) governing atherosclerotic intimal calcification remains to be elucidated. Atherosclerotic calcification of coronary artery is a significant risk for the unsuccessful coronary intervention and balloon-induced coronary artery dissection. 5 Calcification score of coronary arteries assessed by electron beam computer tomography has been reported to correlate well with the incidence of cardiovascular diseases. 6 Furthermore, calcification was found to be a reliable marker of plaque instability, defined as plaques that have undergone rupture using autopsy specimens. 7 However, there is a controversy around this with arguments describing calcification as a marker of plaque stability as well. Negative correlation between extensive calcification and plaque instability was shown, and the pattern of calcification rather than the volume of calcification was reported to be important for the plaque vulnerability. 8, 9 Taken together, inhibition of atherosclerotic calcification might be a promising approach to treat and prevent ischemic cardiovascular diseases.
Many recent findings have suggested that vascular calcification is a process actively regulated through machinery similar to bone calcification. Molecules that play a key role in the bone calcification such as matrix gamma-carboxyglutamic acid protein (MGP) and bone morphogenetic protein-2 (BMP-2) have been identified in blood vessels particularly at sites of medial calcification and calcified atherosclerotic plaques. 10 -13 Moreover, their expressions are differentially regulated between nondiseased and diseased vessels. BMP-2 initiates osteoblastic differentiation of mesenchymal precursor cells to induce mineral crystal precipitation into collagen fibrils. 14, 15 In fact, locally administered BMP-2 is sufficient to induce ectopic calcification in vivo in the presence of proper extracellular matrix. 16, 17 On the other hand, MGP prevents mineral crystal precipitation as well as interferes with the BMP-2 osteogenic signals to inhibit calcification. 18 Strikingly, MGP-deficient mice demonstrated severe aortic calcification despite its normal plasma calcium and phosphate concentration. 19 Of note, VSMCs-specific reexpression of MGP completely rescued the aortic calcification, whereas raising the level of circulating MGP in blood failed to do so in MGPϪ/Ϫ mice. 20 VSMCs normally reside in the vessel wall media in a differentiated state, wherein their contractile properties regulate the vascular tone. However, VSMCs have a unique feature characterized by the ability to enter a synthetic state of proliferation. 21 In atherosclerotic legion, VSMCs dedifferentiate into synthetic type in response to injury and/or growth factors and cytokines and migrate into atherosclerotic intima to contribute to the progression of atherosclerosis. [22] [23] [24] However, it remains unclear whether dedifferentiated VSMCs play a role in the formation of atherosclerotic intimal calcification. In the present study, we investigated the gene expressions of bone-calcification regulatory factors in redifferentiated and dedifferentiated VSMCs in vitro and found that paracrine osteogenic signals via BMP-2 were significantly enhanced when VSMCs became dedifferentiated. Moreover, BMP-2 was highly expressed in the ␣SM-actinpositive VSMCs localized in atherosclerotic intima in vivo. Finally, we demonstrated that overexpression of BMP-2 in VSMCs led to the enhanced atherosclerotic intimal calcification in vivo by using BMP-2-transgenic (Tg) mice.
Materials and Methods

Cell Culture
Human coronary artery smooth muscle cells (VSMCs) were obtained from Cambrex and used before passage 7 for all experiments. VSMCs were regularly cultured in SmGM-2 medium (Cambrex) supplemented with 5% FBS, insulin, basic fibroblast growth factor and epidermal growth factor. To prepare conditioned medium (CM) from dedifferentiated VSMCs, cells were incubated in DMEM supplemented with 5% FBS for 24 hours. Redifferentiation of VSMCs was induced by incubating cells in serum-and supplementfree basal medium for 72 hours. To prepare CM from redifferentiated VSMCs, cells were incubated in serum-free DMEM for 24 hours. After collection of supernatants, FBS was added to 5%. C2C12 cells were regularly cultured in DMEM supplemented with 15% FBS. To examine osteoblastic differentiation of C2C12 cells, cells were incubated in the control medium (fresh DMEM supplemented with 5% FBS) or CM from redifferentiated or dedifferentiated VSMCs for 7 days.
Generation of BMP-2-Tg Mouse
To prepare the transgene, cDNA encoding BMP-2 followed by SV40 poly A signal was inserted downstream of human ␣SM-actin promoter and enhancer. 25 Heterozygote BMP-2-Tg mice (C57BL6 background) were mated with wild-type C57BL6 mice to obtain transgenic offsprings. For all experiments, heterozygote transgenic mice were used in order to avoid the possibility of unexpected gene knockout (KO) by integrations of the transgenes. BMP-2-Tg/apolipoprotein (apo)E-KO mice were fed with high cholesterol diet containing 16.5% fat and 1.25% cholesterol (Oriental Yeast) for 25 weeks. Calcification area was quantitatively analyzed by measuring the alizarin res-S or von Kossa-stained area in atherosclerotic intima. Images were digitally captured, and the staining-positive calcified areas were manually measured by using the Image-J software. The mean of values for apoE-KO control group was considered as 100%, with which each value was normalized. All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee of the Kyoto Prefectural University School of Medicine.
Statistical Analysis
Differences between groups were analyzed using Student's t test. Statistical comparisons between more than 3 groups were performed by 1-way ANOVA and post hoc multiple comparison with Bonferroni/Dunn test. PϽ0.05 was considered significant. Data are presented as meanϮSD as indicated.
Results
Redifferentiation of VSMCs in Culture
VSMCs cultured in the growth medium supplemented with serum and/or growth factors are known to be in dedifferentiated state. 26, 27 Redifferentiation of VSMCs into contractile type was induced by serum and supplement depletion for 72 hours. 28 After a 72-hour incubation in serum and supplementfree medium, VSMCs became spindle shaped in morphology, which is characteristic for differentiated phenotypes ( Figure  1A ). 29 To further confirm their redifferentiation, we analyzed the expressions of VSMC-specific contractile proteins, such as ␣-smooth muscle actin (␣SMA), smooth muscle myosin heavy chain-2, smooth muscle 22␣, and calponin. All of these differentiation markers were significantly upregulated in redifferentiated VSMCs as compared with those in dedifferentiated cells ( Figure 1B ).
Dedifferetiation Led to Enhanced BMP-2 Expression in VSMCs
We then examined the gene expressions of bone-calcification regulatory factors in redifferentiated and dedifferentiated VSMCs. We found that BMP-2, a potent initiator for osteoblast differentiation, was significantly upregulated in dedifferentiated VSMCs compared with that in redifferentiated VSMCs ( Figure  1C ). Furthermore, endogenous antagonists for BMP-2 signaling, such as noggin, chordin, and MGP, were all downregulated in dedifferentiated VSMCs ( Figure 1C ), suggesting that paracrine osteogenic signals via BMP-2 might be markedly enhanced when VSMCs become dedifferentiated.
Consistent with the altered mRNA expression, BMP-2 protein expression was significantly increased, whereas MGP protein expression was significantly reduced in dedifferentiated VSMCs ( Figure 1D ). We also confirmed the secretion of mature BMP-2 into the culture medium of dedifferentiated VSMCs ( Figure 1E ).
Because VSMCs have been reported to transdifferentiate into osteoblast-like cells in response to various stimuli, 30 -34 we examined whether dedifferentiated VSMCs also acquire osteoblast-like phenotypes. Osteoblastic markers, such as runtrelated transcription factor-2 (RUNX-2) and type I collagen, 35, 36 were rather downregulated, whereas another osteoblastic marker, alkaline phosphatase (ALP) expression, was not changed in dedifferentiated VSMCs as compared with those in redifferentiated VSMCs ( Figure 1F ). These results suggest that VSMCs do not transdifferentiate into osteoblast-like cells during the dedifferentiation.
Paracrine Osteogenic Signals via BMP-2 Are Enhanced in Dedifferentiated VSMCs
To investigate the paracrine osteogenic signals in VSMCs, myogenic mesenchymal C2C12 cells were incubated in the control medium (DMEM supplemented with 5% FBS) or in the CM prepared from either redifferentiated or dedifferentiated VSMCs. CM from dedifferentiated VSMCs induced osteoblastic differentiation of C2C12 cells assessed by RUNX-2 and ALP expressions, whereas CM from redifferentiated VSMCs did not (Figure 2A) . Notably, short interfering RNA-mediated knockdown of BMP-2 in dedifferentiated VSMCs abolished the induction of ALP expression, whereas partly abrogated RUNX-2 induction in C2C12 cells incubated with the CM (Figure 2A ). Type I collagen and osterix expressions were downregulated in C2C12 cells when incubated with VSMCs-CM (supplemental Figure I , available online at http:// atvb.ahajournals.org), although the mechanism is unclear. CM from dedifferentiated VSMCs, however, enhanced the type I collagen expression as compared with that in C2C12 cells treated with CM from redifferentiated VSMCs, which was abolished by the BMP-2-knockdown (supplemental Figure I) . Knockdown of BMP-2 in dedifferentiated VSMCs was confirmed by quantitative PCR ( Figure 2B ). These results indicate that paracrine osteogenic signals via BMP-2 are remarkably enhanced in VSMCs when they enter the dedifferentiated state.
Generation of BMP-2-Tg Mouse
We then investigated the in vivo expression of BMP-2 in atherosclerotic legion in apoE-deficient mice. BMP-2-positive Figure 1 . Redifferentiation of human VSMCs in culture. A, After serum and growth supplements deprivation, VSMCs became elongated and spindle shaped in morphology. Scale bar, 100 m. B, Redifferentiated VSMCs highly expressed VSMC-differentiation markers, such as ␣SMA, smooth muscle myosin heavy chain-2 (SM-MHC2), smooth muscle 22␣, and calponin, as compared with dedifferentiated cells. *PϽ0.05 vs dedifferentiated VSMCs (nϭ3 each). C, BMP-2 expression was significantly upregulated, whereas endogenous antagonists for BMP-2 signaling, such as chordin, noggin, and MGP, were all downregulated in dedifferentiated VSMCs as compared with those in redifferentiated cells. *PϽ0.05 vs redifferentiated VSMCs (nϭ6 each). D, Protein expression of BMP-2 was significantly increased in dedifferentiated VSMCs, whereas MGP was reduced as compared with those in redifferentiated VSMCs (Rediff-VSMCs). *PϽ0.01 vs redifferentiated VSMCs (nϭ3 each). E, Mature BMP-2 was detected in the CM from dedifferentiated VSMCs (DediffVSMCs). Recombinant human BMP-2 (rBMP-2) was used as a positive control, and the control medium was used as a negative control. F, Significantly less expression of RUNX-2 and type I collagen ␣ chain (Coll-Ia) was observed in dedifferentiated VSMCs than in redifferentiated VSMCs. *PϽ0.01 vs redifferentiated VSMCs (nϭ6 each). There was no difference of ALP expression between redifferentiated and dedifferentiated VSMCs. cells were localized in atherosclerotic intima, and it appeared that both ␣SMA-positive VSMCs and macrophage-3 antigenpositive macrophages coexpressed BMP-2 ( Figure 2C ), suggesting that dedifferentiated VSMCs and macrophage mainly produce BMP-2 in atherosclerotic intima. Of note, the expression of BMP-2 was barely detected in the medial VSMCs in differentiated state ( Figure 2C ). These results further support our hypothesis that dedifferentiated VSMCs migrating into atherosclerotic intima play a crucial role in the atherosclerotic intimal calcification through activating paracrine osteogenic signals via BMP-2 ( Figure 2D ).
To investigate this hypothesis in vivo, we generated BMP-2-Tg mice using ␣SMA-promoter and obtained 2 independent lines of BMP-2-Tg mice. Expression of BMP-2 in aorta was increased in both BMP-2-Tg1 and BMP-2-Tg2 mice to a similar extent as compared with that in wild-type mice ( Figure 3A) . Accordingly, phosphorylation of small mother against decapentaplegic 1/5/8, down-stream molecules for BMP-2 signaling, was enhanced in aorta of BMP-2-Tg1 and BMP-2-Tg2 mice ( Figure 3A) . Enhanced expression of BMP-2 in ␣SMA-positive cells was also confirmed by immunohistochemistry ( Figure 3B ). BMP-2-Tg mice were then crossed with apoE-deficient mice (apoE-KO) to generate BMP-2-Tg/apoE-KO mice. Body weight, mean blood pressure, and heart rate were not different between BMP-2-Tg/ apoE-KO and apoE-KO mice ( Figure 3C ).
BMP-2-Tg/apoE-KO mice were fed a high cholesterol diet for 25 weeks, and then the progression of atherosclerosis and atheroscrerotic intimal calcification was examined. Atherosclerotic plaque size, as well as oil red-O-positive area in BMP-2-Tg1/apoE-KO, was not different from that in apoE-KO mice ( Figure 4A ). Also, there was no significant difference in serum cholesterol, triglyceride, phosphate, and calcium concentration between apoE-KO and BMP-2-Tg1/ apoE-KO mice (supplemental Figure II) . Nevertheless, we identified significantly accelerated calcification in atherosclerotic intima in BMP-2-Tg1/apoE-KO mice as compared with that in apoE-KO mice ( Figure 4B ). Similar results were obtained in another independent line, BMP-2-Tg2/apoE-KO mice (supplemental Figure IIIA and IIIB) . Movat's pentachrome and Massons's trichrome stainings of atherosclerotic plaques were also performed ( Figure 4C ).
We then investigated the presence of osteoblast-like cells in atherosclerotic intima of apoE-KO and BMP-2-Tg/ apoE-KO mice. Osteoblast-like cells expressing ALP were detected in atherosclerotic intima in BMP-2-Tg1/apoE-KO mice more frequently than in apoE-KO mice, suggesting that paracrine osteogenic signals via BMP-2 play an important role in the emergence of osteoblast-like cells in atherosclerotic intima ( Figure 4D ). Also, it appeared that only a small number of ALP-positive cells coexpressed ␣SMA, and most osteoblast-like cells were negative for ␣SMA ( Figure 4D ). In addition, ␣SMA/ALP-double positive cells that imply osteoblast-like cells derived from VSMCs in atherosclerotic intima were not different between BMP-2-Tg/apoE-KO and apoE-KO mice ( Figure 4D ). These results suggest that dedifferentiated VSMCs contribute to the atherosclerotic intimal calcification by releasing BMP-2 in a paracrine fashion rather than through self-transformation into osteoblast-like cells.
Discussion
Vascular calcification is associated with high risk of cardiovascular and peripheral artery diseases, whereas it had been considered as a result of passive precipitation of mineral crystals into the blood vessels. However, recent evidence has suggested that vascular calcification is a process actively regulated by bone calcification regulatory factors locally expressed in blood vessels. 3, 37, 38 In the present study, we found that dedifferentiated VSMCs migrating into atherosclerotic intima have a potential to release BMP-2 and cause the induction of osteoblast-like cells in intima to contribute to the formation of atherosclerotic calcification.
Our in vitro studies clearly demonstrated that VSMCs induce the osteoblastic differentiation of mesenchymal precursor cells in a paracrine fashion only when they enter the dedifferentiated state. Given that redifferentiated VSMCs expressed BMP-2 at nearly half the level of dedifferentiated cells, and that BMP-2 signals are tightly regulated by its antagonists, 39 downregulation of BMP-2 antagonists in dedifferentiated VSMCs might be important as well for the enhanced paracrine osteogenic signals via BMP-2.
Somewhat unexpectedly, we observed no medial calcification in BMP-2-Tg/apoE-KO mice even when fed a high cholesterol diet. In contrast, previous studies reported that systemic administration of BMP-2 induced significant medial calcification in low-density lipoprotein receptor-deficient Increased expression of BMP-2 was detected in ␣SMA-positive VSMCs. Scale bar, 100 m. C, There is no difference of body weight, heart rate, and mean blood pressure between apoE-KO and BMP-2-Tg1/apoE-KO mice.
mice fed a high-fat diet, presumably through activating muscle segment homeobox-2-wingless-int-1 signaling at adventitia. 40 -42 This might be, in part, due to: (1) different genetic background of mice used in the experiments (apoEϪ/Ϫ versus low-density lipoprotein receptorϪ/Ϫ), (2) insufficient BMP-2 expression to initiate the muscle segment homeobox-2-wingless-int-1 osteogenic signaling in our model, especially at adventitia, and (3) difference of the ingredients in the fed diet. In fact, mRNA expression of muscle segment homeobox-2 was not enhanced in the aorta of BMP-2-Tg/apoE-KO mice as compared with that in apoE-KO mice (supplemental Figure IV) . Nevertheless, further analysis is needed to address this issue.
The molecular mechanism(s) responsible for the induction of BMP-2 in dedifferentiated VSMCs is still unclear. VSMCs dedifferentiate into synthetic type in response to injury and/or growth factors and cytokines. Activation of nuclear factor B in VSMCs, which is initiated immediately after injury, is closely associated with VSMCs proliferation. 43, 44 On the other hand, nuclear factor B has been reported to activate BMP-2 expression in osteoblasts as well as in chondrocytes. 45, 46 Therefore, activation of nuclear factor B might be a possible mechanism linking VSMCs dedifferentiation and enhanced BMP-2 expression.
The origin of osteoblast-like cells in the blood vessel wall remains to be elusive. Calcifying vascular cells isolated from aortic media, vascular pericytes, and circulating osteoprogenitor cells, including monocytes and VSMCs, are the most likely candidate cells that transdifferentiate into osteoblast-like cells in blood vessels. [47] [48] [49] [50] [51] [52] [53] Perhaps, origin of osteoblast-like cells may be heterogenous and/or different depending on the type and/or progression of vascular calcification. Our in vitro and in vivo data suggest that dedifferentiated VSMCs are unlikely to be the major origin for the osteoblast-like cells in the atherosclerotic intima. This is consistent with the previous report showing that RUNX-2-positive osteoblast-like cells in plaques were not associated with VSMCs in human specimens. 11 However, because VSMCs-derived osteoblast-like cells were reported to lose the expression of SMC markers, 32,51 our present study may have limitations to provide solid evidence to support our hypothesis that BMP-2 produced by dedifferentiated VSMCs accelerates intimal calcification mainly via paracrine mechanisms. Further analysis would be required to address the exact origin of osteoblast-like cells and the mechanisms for the accelerated atherosclerotic intimal calcification observed in the BMP-2-Tg/apoE-KO mice.
Taken together, we demonstrated an important role of dedifferentiated VSMCs in the formation of atherosclerotic intimal calcification presumably through giving rise to the paracrine osteogenic signals via BMP-2. Considering the broad biological functions of BMP-2 besides osteogenesis, 54 -56 inhibition of BMP-2 signaling may lead to unexpected and/or unfavorable effects despite its potential to prevent vascular calcification. Therefore, inhibition of dedifferentiation, as well as promotion of redifferentiation, of VSMCs might be a feasible and ideal approach to prevent the atherosclerotic intimal calcification in addition to preventing the progression of the intimal thickening. 
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